FDA WARNING_LETTER - Skin Beauty Solutions - April 30, 2024

On July 25, 2024, the FDA issued a Warning Letter to Cassandra Pryor regarding chemical peel drug products sold on https://www.skinbeautysolutions.com/. The FDA reviewed the website in April 2024 and found numerous chemical peel products, including various strengths of lactic acid, glycolic acid, combination glycolic and lactic acid, and salicylic acid products, offered for sale in the U.S.

The FDA determined these products are unapproved new drugs, violating sections 505(a) and 301(d) of the FD&C Act (21 U.S.C. 355(a) and 331(d)). The Agency expressed concern about public health risks, citing potential skin injuries like burns, wounds, pain, swelling, and scarring, with adverse event reports requiring emergency or specialized care.

The products are considered drugs under section 201(g)(1) of the FD&C Act (21 U.S.C. 321(g)(1)) due to intended uses such as "Clears Acne & Scars," "Removes Dead Skin Cells," "Prevents Fine lines & Wrinkles," and "Removes Blackheads." Specific product claims cited include those for "LACTIC Acid Skin Chemical Peel 90%," "GLYCOLIC ACID Skin Cosmetic Grade Peel 70%," "